PT  - JOURNAL ARTICLE
AU  - Hang, Ching Nam
AU  - Yu, Pei-Duo
AU  - Chen, Siya
AU  - Tan, Chee Wei
AU  - Chen, Guanrong
TI  - MEGA: Machine Learning-Enhanced Graph Analytics for Infodemic Risk Management
AID  - 10.1101/2020.10.24.20215061
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2020.10.24.20215061
4099  - http://medrxiv.org/content/early/2023/09/13/2020.10.24.20215061.short
4100  - http://medrxiv.org/content/early/2023/09/13/2020.10.24.20215061.full
AB  - The COVID-19 pandemic brought not only global devastation but also an unprecedented infodemic of false or misleading information that spread rapidly through online social networks. Network analysis plays a crucial role in the science of fact-checking by modeling and learning the risk of infodemics through statistical processes and computation on mega-sized graphs. This paper proposes MEGA, Machine Learning-Enhanced Graph Analytics, a framework that combines feature engineering and graph neural networks to enhance the efficiency of learning performance involving massive graphs. Infodemic risk analysis is a unique application of the MEGA framework, which involves detecting spambots by counting triangle motifs and identifying influential spreaders by computing the distance centrality. The MEGA framework is evaluated using the COVID-19 pandemic Twitter dataset, demonstrating superior computational efficiency and classification accuracy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo